Biosynthesis of proMMP-9/CSPG Heteromer Involves a Rottlerin-Sensitive Pathway
Author Information
Author(s): Malla Nabin Berg, Eli Moens, Ugo Uhlin-Hansen, Lars Winberg, Jan-Olof Winberg
Primary Institution: Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
Hypothesis
The study aims to determine whether different compounds known to stimulate the synthesis of proMMP-9 and CSPGs can also increase the syntheses of proMMP-9/CSPG heteromers in THP-1 cells.
Conclusion
The biosynthesis of the proMMP-9/CSPG heteromer and proMMP-9 in THP-1 cells involves a Rottlerin-sensitive pathway that is different from the pathway involved in CSPG biosynthesis.
Supporting Evidence
- Only PMA significantly increased the biosynthesis of the proMMP-9/CSPG heteromer.
- Rottlerin repressed the biosynthesis of proMMP-9/CSPG and its components.
- Lower concentrations of Rottlerin were needed to reduce CSPG than to repress the synthesis of the heteromer and MMP-9.
Takeaway
This study found that a specific pathway involving a substance called Rottlerin helps cells make a special protein complex that includes an enzyme and a sugar-protein mix, which is important for how cells work.
Methodology
The study used affinity chromatography, zymography, and radioactive labeling to test the effects of various macrophage stimulators on the synthesis of the proMMP-9/CSPG heteromer in THP-1 cells.
Limitations
The study did not explore the long-term effects of Rottlerin on cell viability beyond 12 hours.
Participant Demographics
The study used the human leukemic monocyte cell line THP-1.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website